European shares kick of week on strong footing, vaccine progress eyed
Reuters
Published Sep 07, 2020 03:26AM ET
Updated Sep 07, 2020 04:50AM ET
By Shreyashi Sanyal
(Reuters) - European shares bounced on Monday after a Wall Street-led rout in technology stocks kept global sentiment subdued in the previous week, with investors keeping a close watch on COVID-19 vaccine developments.
Australia expects to receive its first batches of a potential COVID-19 vaccine in January after a deal was struck with CSL (AX:CSL) to manufacture two vaccines, one developed by rival AstraZeneca (L:AZN) and Oxford University, and another in CSL's own labs with the University of Queensland.
AstraZeneca rose 1.6%, with the European healthcare sector index (SXDP) jumping 1.1%.
Sanofi (PA:SASY) rose 1% after it said a coronavirus vaccine it is developing with Britain's GlaxoSmithKline (L:GSK) was likely to be priced at less than 10 euros.
The STOXX 600 index (STOXX) was 1% higher, with Frankfurt shares (GDAXI) leading gains after rising 1.2%.
Autos (SXAP) led sectoral gains in Europe after analysts at JP Morgan said the overall tone for production outlook in the European autos sector was "upbeat", following its meetings with industry leaders.
Insurers (SXIP) and financial services sub-indexes climbed in early trading, while telecoms (SXKP) rose the least, suggesting a risk-on mood.
The STOXX 600 has remained stuck in a tight range since June, as a euro zone economic recovery appeared to be losing steam.
A batch of middling economic data last week bolstered expectations the ECB would maintain an accommodative stance to support inflation, in line with the U.S. Federal Reserve.
"Liquidity and low interest rates alone cannot be the solution to everything, so it's essential to see continued improvement in economic data and an end to the pandemic for sustainable upside in risk assets," said Hussein Sayed, chief market strategist at FXTM.
Data showed German industrial output rose far less than expected in July, suggesting Europe's largest economy faces a slow return to production levels that preceded the crisis unleashed by the coronavirus pandemic.
"German industry eked out a meagre increase in production in July, leaving output still well below its pre-crisis level. Production is likely to have increased again in August, but we now seem to be past the period of rapid catch-up growth," said Jack Allen-Reynolds, senior Europe economist at Capital Economics.
European banks (SX7P) turned flat following a strong opening, after a rally last week on M&A negotiations between Bankia (MC:BKIA) and Caixabank (MC:CABK).
Dechra (L:DPH) jumped 9%, to the top of STOXX 600, after its profit beat expectations.
Get The News You Want
U.S. markets are closed on Monday for the Labor Day holiday.
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.